{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":37,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049634500727.png","picWidth":40,"picHeight":29,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

联系电话：0851-33411018（行政部）   0851-88173360（销售部）    股票代码：SZ 002424

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":550,"cheight":381,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889249.png","picWidth":550,"picHeight":381,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
贵州百灵企业集团制药股份有限公司
股票代码：SZ 002424
查看更多最新公告>
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":634,"cheight":56,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049634500733.png","picWidth":630,"picHeight":56,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

走进百灵

专精于药 · 专注于人

 贵州百灵企业集团制药股份有限公司（以下简称“贵州百灵”）是一家从事苗药研发、生产、销售于一体的医药上市公司，注册资本14.112亿元，总资产70.59亿元，员工5961人。2010年6月，公司在深圳证券交易所成功上市（股票代码：SZ 002424）。公司明确围绕“强化公司在苗药领域的优势地位，力争成为中成药领域具有核心竞争优势的企业”为战略发展目标，以实施“科技苗药、文化苗药、生态苗药”为抓手，致力打造拥有大健康全产业链的企业集团。

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":365,"cheight":129,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"集团概况","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889219.png","picWidth":360,"picHeight":129,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"1","linkName":"集团概况","linkKey":"page","linkUrl":"page.html?id=675381845688348","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":363,"cheight":129,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"集团概况","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889221.png","picWidth":"373","picHeight":"129","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"1","linkName":"集团概况","linkKey":"page","linkUrl":"page.html?id=675381845688348","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":363,"cheight":129,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"药材基地","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889220.png","picWidth":"363","picHeight":"129","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"1","linkName":"药材基地","linkKey":"page","linkUrl":"page.html?id=675381845688358","jsonData":{}}}
致力于推动苗药品种的科研创新
实现传统苗药现代化、科技化

持续挖掘和探索苗药宝库，以传承

和发扬民族医药文化为企业使命

布局中药材种植产业，加强道地

药材保护，助力产业化精准扶贫

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":754,"cheight":61,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049634500735.png","picWidth":754,"picHeight":61,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

产品与服务

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":754,"cheight":61,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049634500735.png","picWidth":752,"picHeight":61,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
  • 非处方药
  • 处方药
  • 大健康产品
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":591,"cheight":57,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049634500734.png","picWidth":590,"picHeight":57,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

百灵动态

关注百灵了解更多最新资讯

  • 百灵新闻
  • 媒体聚焦
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":243,"cheight":154,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"https://www.gzbl.com/displaynews.html?newsId=707814964068363","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/719609221087247.jpg","picWidth":"274","picHeight":"159","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"https://www.gzbl.com/displaynews.html?newsId=707814964068363","linkUrl":"https://www.gzbl.com/displaynews.html?newsId=707814964068363","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":274,"cheight":159,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"https://www.gzbl.com/displaynews.html?newsId=707814955679751","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/707130554318899.jpg","picWidth":"274","picHeight":"159","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"https://www.gzbl.com/displaynews.html?newsId=707814955679751","linkUrl":"https://www.gzbl.com/displaynews.html?newsId=707814955679751","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":274,"cheight":159,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"https://www.gzbl.com/displaynews.html?newsId=687373503430782","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049995210777.jpg","picWidth":"274","picHeight":"159","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"https://www.gzbl.com/displaynews.html?newsId=687373503430782","linkUrl":"https://www.gzbl.com/displaynews.html?newsId=687373503430782","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":274,"cheight":159,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"https://www.gzbl.com/displaynews.html?newsId=687373503430779","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/719609221087257.jpg","picWidth":"274","picHeight":"159","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"https://www.gzbl.com/displaynews.html?newsId=687373503430779","linkUrl":"https://www.gzbl.com/displaynews.html?newsId=687373503430779","jsonData":{}}}

贵州百灵糖宁通络国家级课题稳步推进 糖前干预临床研究子课题正式启动

贵州百灵蝉联贵州企业“双百强”

前20强！贵州百灵荣登“2021中国非处方药企业及产品榜”

再下一城！贵州百灵与武汉市中医医院合作共研糖宁通络

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

2021-11-09

2021-11-02

2021-10-20

2021-10-20

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":263,"cheight":156,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"https://www.gzbl.com/displaynews.html?newsId=707814964068412","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/719609221087247.jpg","picWidth":"263","picHeight":"157","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"https://www.gzbl.com/displaynews.html?newsId=707814964068412","linkUrl":"https://www.gzbl.com/displaynews.html?newsId=707814964068412","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":263,"cheight":157,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889244.webp","picWidth":263,"picHeight":157,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":263,"cheight":158,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"https://www.gzbl.com/displaynews.html?newsId=687373352435825","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049785495651.jpg","picWidth":"263","picHeight":"157","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"https://www.gzbl.com/displaynews.html?newsId=687373352435825","linkUrl":"https://www.gzbl.com/displaynews.html?newsId=687373352435825","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":263,"cheight":159,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"https://www.gzbl.com/displaynews.html?newsId=687373352435813","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049785495559.jpg","picWidth":"263","picHeight":"157","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"https://www.gzbl.com/displaynews.html?newsId=687373352435813","linkUrl":"https://www.gzbl.com/displaynews.html?newsId=687373352435813","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

2021-11-09

2020-11-01

2020-11-01

2020-11-01

11月8日，国家中医药管理局中医药科学技术研究专项课题·糖宁通络系列研究子课题“糖宁通络片在糖尿病前期人群中的有效性和安全性临床研究”组长...详细>

在此次新冠肺炎疫情防控阻击战中，贵州百灵企业集团制药股份有限公司充分发挥企业在药品生产、物资采购、配送等方面的优势，充分整合资源，保障药品生产、供应...详细>

随着新型冠状病毒感染的肺炎疫情持续发酵，作为全国苗药龙头企业，贵州百灵通过成立疫情工作领导小组、24小时人员在岗应急机制、提前复工复产等措施...详细>

证券日报 | 贵州百灵糖宁通络国家级课题稳步推进 糖前干预临床研究子课题正式启动

贵州广播电视台 | 一手抓抗疫 一手抓生产

| 制药人当有济世心！贵州百灵加班...

安顺日报 | 贵州百灵：整合资源全力抗“疫”


中国网财经 | 贵州百灵全力保障防控物资供应

提前复工复产保障药品稳定供应

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":751,"cheight":64,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889216.png","picWidth":751,"picHeight":64,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

投资者关系

与您共享贵州百灵的发展和成绩